Back to Journals » Neuropsychiatric Disease and Treatment » Volume 14

Comparison of the efficacy and safety of 4 and 2 mg/day brexpiprazole for acute schizophrenia: a meta-analysis of double-blind, randomized placebo-controlled trials

Total article views   Abstract views HTML views PDF downloads Totals
3,223 Dovepress* 2,914 211+ 350 3,125
PubMed Central* 0 98 74 98
Totals 2,914 309 424 3,223
*Since 1 October 2018
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
18 1 0 0 7 10

View citations on PubMed Central and Google Scholar